Science
Mechanism of Action
By mimicking the natural human peptide Cathelicidin (LL-37), it employs a sophisticated intracellular targeting mechanism to inhibit pathogen proliferation. It modulates the skin's inflammatory response by suppressing pro-inflammatory cytokines and reducing mast cell infiltration, effectively stabilizing the epidermal environment.
Research
Clinical Evidence
High confidence0.5%
Key findings
- 01 In vivo studies using BALB/c models demonstrated a 30% reduction in epidermal thickness and 50% reduction in dermal thickness, indicating significant anti-inflammatory efficacy in atopic conditions.
- 02 In vitro testing confirmed potent antibacterial activity against C. acnes and MRSA at concentrations as low as 8-16 mg/dL via non-membrane-disruptive pathways.
Transparency
Dusting Analysis
Due to its high efficacy at low concentrations, brands often include it at 'label claim' levels (below 0.1%) which may fail to trigger the peptide-mimetic anti-inflammatory response required for therapeutic results.
The Formula
Formulation
Stability
Highly stable in aqueous solutions as an HCl salt; should be incorporated during the cool-down phase (below 40°C) to maintain structural integrity.
Synergies
- Ceramides
- Glycerin
- Panthenol
Conflicts
- Anionic surfactants (SLS/SLES)
- High concentrations of Carbomer
- Strongly alkaline bases
Safety
Safety Profile
Recognized by EU CosIng and Korean MFDS as safe; its frequent use in infant and feminine care products underscores its gentle profile for mucosal and hypersensitive skin.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A precise, bio-inspired tool for managing inflammatory skin disorders and bacterial imbalances without the irritation associated with traditional actives.
Related
Similar Ingredients
Finding similar ingredients…